SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-12-032071
Filing Date
2012-05-02
Accepted
2012-05-02 17:03:26
Documents
4
Group Members
DEFIANTE FARMACEUTICA S.A.PAOLO CAVAZZA

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-11144_1sc13da.htm SC 13D/A 98571
2 EX-22 a12-11144_1ex22.htm EX-22 52376
3 EX-23 a12-11144_1ex23.htm EX-23 68893
4 GRAPHIC g111441ke01i001.jpg GRAPHIC 4601
  Complete submission text file 0001104659-12-032071.txt   227786
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 12806187
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A